表紙
市場調査レポート

閉塞性冠動脈疾患:世界の治験レビュー

Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 314741
出版日 ページ情報 英文 56 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
閉塞性冠動脈疾患:世界の治験レビュー Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2014
出版日: 2014年09月21日 ページ情報: 英文 56 Pages
概要

当レポートでは、閉塞性冠動脈疾患に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

イントロダクション

  • 閉塞性冠動脈疾患
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数

G7諸国での治験件数:心血管疾患の治験における閉塞性冠動脈疾患の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

閉塞性冠動脈疾患の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Sanofi
    • Matrizyme Pharma Corporation
    • Getinge AB
    • CryoLife, Inc.
  • 代表的な研究機関・病院の治験の概要
    • Yonsei University
    • Universitair Medisch Centrum Utrecht
    • Adult Stem Cell Research Center
    • North Texas Veterans Healthcare System
    • University of Ulm
    • University of Patras
    • Samsung Medical Center
    • New York University School of Medicine
    • University of Catania
    • National Heart, Lung, and Blood Institute

5つの代表的な治験のプロファイル

付録

目次

GlobalData's clinical trial report, "Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2014" provides data on the Occlusive Coronary Artery Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Occlusive Coronary Artery Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Occlusive Coronary Artery Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Occlusive Coronary Artery Disease
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Occlusive Coronary Artery Disease Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Matrizyme Pharma Corporation
      • Clinical Trial Overview of Matrizyme Pharma Corporation
      • Getinge AB
      • Clinical Trial Overview of Getinge AB
      • CryoLife, Inc.
      • Clinical Trial Overview of CryoLife, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Yonsei University
      • Clinical Trial Overview of Yonsei University
      • Universitair Medisch Centrum Utrecht
      • Clinical Trial Overview of Universitair Medisch Centrum Utrecht
      • Adult Stem Cell Research Center
      • Clinical Trial Overview of Adult Stem Cell Research Center
      • North Texas Veterans Healthcare System
      • Clinical Trial Overview of North Texas Veterans Healthcare System
      • University of Ulm
      • Clinical Trial Overview of University of Ulm
      • University of Patras
      • Clinical Trial Overview of University of Patras
      • Samsung Medical Center
      • Clinical Trial Overview of Samsung Medical Center
      • New York University School of Medicine
      • Clinical Trial Overview of New York University School of Medicine
      • University of Catania
      • Clinical Trial Overview of University of Catania
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Region, 2014*
  • Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Occlusive Coronary Artery Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Occlusive Coronary Artery Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Occlusive Coronary Artery Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Matrizyme Pharma Corporation, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Getinge AB, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by CryoLife, Inc., 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitair Medisch Centrum Utrecht, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Adult Stem Cell Research Center, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by North Texas Veterans Healthcare System, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ulm, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Patras, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Catania, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*

List of Figures

  • Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Occlusive Coronary Artery Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Occlusive Coronary Artery Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Occlusive Coronary Artery Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Occlusive Coronary Artery Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Occlusive Coronary Artery Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top